Based on my prior research US TNBC is estimated to
Post# of 148175
(Total Views: 379)
Posted On: 11/15/2019 4:05:34 PM
Re: ClosetInvestor #11022
Based on my prior research US TNBC is estimated to be 40,000 patients diagnosed annually. 95% over-express CCR5.....so 38,000 annual US market. I understand these cancer patients would be on leronlimab for the remainder of their lives, so this number grows exponentially every year.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼